Lista de obras - Emma C Morris - Dominio Público Uruguay

A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma.

artículo científico publicado en 2012

Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults.

artículo científico publicado en 2012

Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity.

artículo científico publicado en 2009

Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma

scientific article published on 01 May 2005

Anti-Müllerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens

scientific article published on 30 March 2020

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure

artículo científico publicado en 2014

Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma.

artículo científico

Cancer gene therapy with T cell receptors and chimeric antigen receptors

artículo científico

Challenges in T cell receptor gene therapy.

artículo científico publicado en 2012

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

artículo científico publicado en 2005

Correction: Anti-Müllerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens

artículo científico publicado en 2020

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

artículo científico publicado en 2011

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

artículo científico publicado en 2003

Editing gene engineering to enhance function

artículo científico publicado en 2018

Engineered T cells Flt around their targets

artículo científico publicado en 2020

Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients.

artículo científico publicado en 2017

Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy

artículo científico publicado en 2016

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma

artículo científico publicado en 2008

Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function

scientific article published on 01 October 2019

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult

artículo científico publicado en 2017

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

artículo científico publicado en 2010

Human MHC Class I-restricted high avidity CD4+ T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.

artículo científico publicado en 2013

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

artículo científico publicado en 2011

Immunotherapy with gene-modified T cells: limiting side effects provides new challenges.

artículo científico publicado en 2013

Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma

artículo científico publicado en 2016

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning

artículo científico publicado en 2013

Lentiviral gene therapy for X-linked chronic granulomatous disease

artículo científico publicado en 2020

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome

artículo científico publicado en 2022

Monoclonal T-cell receptors: new reagents for cancer therapy.

artículo científico publicado en 2007

Murine serpin 2A is a redox-sensitive intracellular protein.

artículo científico publicado en 2003

Optimizing T-cell receptor gene therapy for hematologic malignancies.

artículo científico publicado en 2016

Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen

scientific article published on 01 June 2002

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

artículo científico publicado en 2004

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

scientific article published on 06 March 2003

Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure

artículo científico publicado en 2011

Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia

artículo científico publicado en 2003

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

artículo científico publicado en 2010

Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma.

artículo científico publicado en 2005

Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity

scientific article published on 01 April 2003

Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support device

scientific article published on 01 May 2003

Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia

article

Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination

artículo científico publicado en 2011

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

artículo científico publicado en 2017

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

artículo científico publicado en 2008

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

scientific article published on 18 June 2020

T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma

artículo científico publicado en 2010

Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses

artículo científico publicado en 2013

X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis

artículo científico publicado en 2016

Lista de obras de Emma C Morris

A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma.

Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults.

Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity.

Allogeneic transplantation for hepatosplenic alphabeta T-cell lymphoma

Anti-Müllerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens

Autologous stem cell transplantation for follicular lymphoma is of most benefit early in the disease course and can result in durable remissions, irrespective of prior rituximab exposure

Autologous stem cell transplantation outcomes in elderly patients with B cell Non-Hodgkin Lymphoma.

Cancer gene therapy with T cell receptors and chimeric antigen receptors

Challenges in T cell receptor gene therapy.

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

Correction: Anti-Müllerian hormone and Inhibin B after stem cell transplant in childhood: a comparison of myeloablative, reduced intensity and treosulfan-based chemotherapy regimens

Donor lymphocyte infusions modulate relapse risk in mixed chimeras and induce durable salvage in relapsed patients after T-cell-depleted allogeneic transplantation for Hodgkin's lymphoma.

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

Editing gene engineering to enhance function

Engineered T cells Flt around their targets

Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients.

Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy

Favorable long-term survival after reduced-intensity allogeneic transplantation for multiple-relapse aggressive non-Hodgkin's lymphoma

Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult

HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning

Human MHC Class I-restricted high avidity CD4+ T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo.

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

Immunotherapy with gene-modified T cells: limiting side effects provides new challenges.

Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin Lymphoma

Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning

Lentiviral gene therapy for X-linked chronic granulomatous disease

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome

Monoclonal T-cell receptors: new reagents for cancer therapy.

Murine serpin 2A is a redox-sensitive intracellular protein.

Optimizing T-cell receptor gene therapy for hematologic malignancies.

Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Pharmacokinetics of alemtuzumab used for in vivo and in vitro T-cell depletion in allogeneic transplantations: relevance for early adoptive immunotherapy and infectious complications

Predominant or complete recipient T-cell chimerism following alemtuzumab-based allogeneic transplantation is reversed by donor lymphocytes and not associated with graft failure

Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

Reduced intensity allogeneic stem cell transplantation for low grade non-Hodgkin's lymphoma.

Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: Limited efficacy of graft-versus-tumor activity

Reversal of severe cholestasis caused by chronic graft-versus-host disease with the MARS liver-support device

Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemia

Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination

Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.

Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma

Wilms' Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses

X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis